Go Pro
→ The $15 Gold Fund That Pays Up to $1,152/Month (From Investors Alley) (Ad)tc pixel
OTCMKTS:TRUMY

Terumo Q1 2027 Earnings Report

Terumo logo
$14.78 +0.39 (+2.71%)
As of 03:58 PM Eastern
ProfileEarnings HistoryForecast

Terumo EPS Results

Actual EPS
$0.30
Consensus EPS
$0.17
Beat/Miss
Beat by +$0.13
One Year Ago EPS
N/A

Terumo Revenue Results

Actual Revenue
$1.97 billion
Expected Revenue
$1.84 billion
Beat/Miss
Beat by +$133.41 million
YoY Revenue Growth
N/A

Terumo Announcement Details

Quarter
Q1 2027
Date
8/7/2026
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Terumo's next earnings date is estimated for Wednesday, November 11, 2026, based on past reporting schedules.

Conference Call Resources

Terumo Earnings Headlines

Terumo Corp. (OTCMKTS:TRUMY) Short Interest Update
September 27, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31055133
Terumo ADR (TRUMY)
September 5, 2026  |  es.investing.comhttps://es.investing.com/equities/terumo-adr
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and stinging losses? Dave Aquino is giving away the exact 11-hour options strategy he uses in volatile markets. You get the plain English blueprint behind the strategy and the very same "rinse and repeat" ticker he's traded nearly 900 times with a 95.3% success rate. It's so simple to understand, you could trade it tomorrow.tc pixel
October 1 at 1:00 AM  |  Base Camp Trading (Ad)
Terumo Corporation (TRUMY) Q1 2027 Earnings Call Prepared Remarks Transcript
August 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4935290-terumo-corporation-trumy-q1-2027-earnings-call-prepared-remarks-transcript
Terumo Corporation (TRUMY) Analyst/Investor Day Transcript
June 12, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4914117-terumo-corporation-trumy-analyst-investor-day-transcript
Terumo ADR Stock Price History
May 17, 2026  |  investing.comhttps://www.investing.com/equities/terumo-adr-historical-data
See More Terumo Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Terumo? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Terumo and other key companies, straight to your email.

About Terumo

Terumo (OTCMKTS:TRUMY) Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other healthcare settings. Founded in 1921 by a group of Japanese medical doctors, the company initially produced clinical thermometers and has since expanded into a global provider of medical devices and related services.

Terumo’s principal businesses include cardiac and vascular products, blood and cell technologies, and general hospital solutions. Its portfolio includes interventional devices and systems used in cardiovascular procedures, blood collection and processing equipment, transfusion products, infusion and injection devices, and other products designed to support patient care and clinical workflows. The company also provides technologies for diabetes management and other specialized medical applications.

Terumo serves healthcare providers and patients internationally through operations and distribution networks spanning Japan, the Americas, Europe, Asia and other markets. Its products are used across a range of medical specialties, including cardiovascular care, blood management, interventional procedures, infusion therapy and hospital operations.

View Terumo Profile
Earnings Tools